We have read with great interest the recent article by Mamidipudi and Cartwright (2009) , in which the authors showed that RACK1 induced apoptosis of human colon cells by inhibiting the expression of antiapoptotic pathways and Src activity, thus leading to death of colon cancer cells.
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We have recently conducted an analysis of RACK1 messenger RNA (mRNA) expression in 127 human breast cancer and 33 non-cancerous breast tissue specimens. The study was carried out using reverse transcriptase-polymerase chain reaction following RNA extraction from frozen samples. The mRNA copy numbers for RACK1 were normalized against the epithelial marker CK19 as previously described (Al Sarakbi et al., 2009 ) in order to adjust for epithelial cellularity in the specimens examined. We observed that RACK1 expression levels were higher in the normal breast tissue compared with the cancer specimens (mean levels were 136 vs 32 in paired samples, P ¼ 0.44). Furthermore, RACK1 mRNA levels were significantly lower in TNM3 tumours compared with TNM1 tumours (0.08 vs 33, P ¼ 0.04). After a median followup of 10 years, high levels of RACK1 mRNA expression were associated with a good clinical outcome. The mean level of expression in patients who remained disease-free was 36 compared with 2.4 in those who had systemic relapse (P ¼ 0.042) or those who had local recurrence (mean ¼ 3.86, P ¼ 0.05).
Our results are consistent with the authors' observation that RACK1 has a novel pre-apoptotic function in human malignancy. However, our results contradict a recent study that looked at the protein expression of RACK1 in human breast cancer and showed that high levels were predictive of a poor clinical outcome (Cao et al., 2009) . Further research is required in order to establish the role of RACK1 as an independent prognostic indicator in human cancer.
